{"id":138782,"date":"2022-06-15T11:20:51","date_gmt":"2022-06-15T11:20:51","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/gyakori-kerdesek\/"},"modified":"2025-09-11T10:06:50","modified_gmt":"2025-09-11T10:06:50","slug":"gyakori-kerdesek","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/hu\/gyakori-kerdesek\/","title":{"rendered":"Gyakori k\u00e9rd\u00e9sek"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;111541&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-514338&#8243; text_weight=&#8221;300&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;140228&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\">Gyakori k\u00e9rd\u00e9sek<\/span>[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-196438&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-195745&#8243; text_size=&#8221;&#8221; text_weight=&#8221;600&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;114728&#8243; text_color_type=&#8221;uncode-palette&#8221;]V\u00c1LASZOK A K\u00c9RD\u00c9SEIRE[\/vc_custom_heading][vc_empty_space empty_h=&#8221;1&#8243;][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112249&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center bottom&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;114217&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-514338&#8243; text_weight=&#8221;300&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;166716&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\">Gyakori k\u00e9rd\u00e9sek<\/span>[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-196438&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-195745&#8243; text_size=&#8221;&#8221; text_weight=&#8221;600&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;105352&#8243; text_color_type=&#8221;uncode-palette&#8221;]V\u00c1LASZOK A K\u00c9RD\u00c9SEIRE[\/vc_custom_heading][vc_empty_space empty_h=&#8221;1&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112248&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;308018&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;2&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-514338&#8243; text_size=&#8221;h4&#8243; text_weight=&#8221;300&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;134194&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\">Gyakori k\u00e9rd\u00e9sek<\/span>[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-196438&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-195745&#8243; text_weight=&#8221;600&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;420235&#8243; text_color_type=&#8221;uncode-palette&#8221;]V\u00c1LASZOK A K\u00c9RD\u00c9SEIRE[\/vc_custom_heading][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; top_divider=&#8221;step_1_2&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; changer_back_color=&#8221;yes&#8221; uncode_shortcode_id=&#8221;120331&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;questions&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;5&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;166430&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;384218&#8243; text_color_type=&#8221;uncode-palette&#8221;]\u00c1ltal\u00e1nos k\u00e9rd\u00e9sek[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;999729&#8243; subheading=&#8221;Eg\u00e9szs\u00e9gi \u00e1llapot\u00e1t a StrateGIST 3 vizsg\u00e1lat ideje alatt folyamatosan figyelemmel k\u00eds\u00e9rj\u00fck. M\u00e9g ha \u00d6nnek k\u00f6zvetlen\u00fcl nem is sz\u00e1rmazik el\u0151nye a vizsg\u00e1latban val\u00f3 r\u00e9szv\u00e9telb\u0151l, az \u00f6sszegy\u0171jt\u00f6tt inform\u00e1ci\u00f3k seg\u00edthetnek a kutat\u00f3knak t\u00f6bbet megtudni az IDRX-42 vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nyr\u0151l \u00e9s a GIST-ben szenved\u0151 feln\u0151tt betegek j\u00f6v\u0151beli kezel\u00e9s\u00e9r\u0151l.&#8221;]Milyen el\u0151ny\u00f6kkel j\u00e1r a StrateGIST 3 programban val\u00f3 r\u00e9szv\u00e9tel?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;146860&#8243; subheading=&#8221;Mint minden gy\u00f3gyszer eset\u00e9ben, a vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nyekn\u00e9l is fenn\u00e1ll a mell\u00e9khat\u00e1sok kock\u00e1zata. Azonban az \u00d6n biztons\u00e1ga a legfontosabb sz\u00e1munkra. Eg\u00e9szs\u00e9gi \u00e1llapot\u00e1t a vizsg\u00e1lat teljes id\u0151tartama alatt szorosan figyelemmel k\u00eds\u00e9rj\u00fck. Egy speci\u00e1lis szak\u00e9rt\u0151i csoport, az \u00fagynevezett Adatmonitoroz\u00f3 Bizotts\u00e1g is ellen\u0151rzi majd az adatokat a vizsg\u00e1lat teljes id\u0151tartama alatt, hogy minden r\u00e9sztvev\u0151 biztons\u00e1g\u00e1t garant\u00e1lj\u00e1k.&#8221;]Van-e kock\u00e1zata a vizsg\u00e1latban val\u00f3 r\u00e9szv\u00e9telnek?[\/vc_custom_heading][vc_custom_heading 1=&#8221;biopharmaceutical&#8221; 2=&#8221;company&#8221; 3=&#8221;IDRx,&#8221; 4=&#8221;Inc.&#8221; 5=&#8221;is&#8221; 6=&#8221;sponsoring&#8221; 7=&#8221;the&#8221; 8=&#8221;clinical&#8221; 9=&#8221;trial.&#8221; 10=&#8221;They&#8221; 11=&#8221;will&#8221; 12=&#8221;pay&#8221; 13=&#8221;the&#8221; 14=&#8221;study&#8221; 15=&#8221;doctor&#8221; 16=&#8221;and&#8221; 17=&#8221;site&#8221; 18=&#8221;staff&#8221; 19=&#8221;to&#8221; 20=&#8221;run&#8221; 21=&#8221;this&#8221; 22=&#8221;trial.&#8221; 23=&#8221;To&#8221; 24=&#8221;learn&#8221; 25=&#8221;more&#8221; 26=&#8221;about&#8221; 27=&#8221;IDRx,&#8221; 28=&#8221;visit&#8221; 29=&#8221;&#8221; 30=&#8221;href=&#8222;&#8222;https:\/\/www.idrx.com&#8222;&#8222;&gt;www.idrx.com&#8221; 31=&#8221;.&#8222;&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;148716&#8243;]Ki a StrateGIST 3 klinikai vizsg\u00e1lat megb\u00edz\u00f3ja?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;203685&#8243; css=&#8221;.vc_custom_1731516055759{margin-top: 10px !important;}&#8221;]<span style=\"font-weight: 400\">A StrateGIST 3 klinikai vizsg\u00e1lat megb\u00edz\u00f3ja az IDRx, Inc. biogy\u00f3gyszer\u00e9szeti v\u00e1llalat. A vizsg\u00e1lat lebonyol\u00edt\u00e1s\u00e1\u00e9rt fizet\u00e9st kapnak a vizsg\u00e1latot v\u00e9gz\u0151 orvosok \u00e9s a helysz\u00edni szem\u00e9lyzet. Az IDRx-r\u0151l tov\u00e1bbi inform\u00e1ci\u00f3kat a <\/span><a href=\"https:\/\/www.idrx.com\/\" target=\"_blank\" rel=\"noopener\">www.idrx.com<\/a> weboldalon tal\u00e1l.[\/vc_column_text][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;150124&#8243; subheading=&#8221;A vizsg\u00e1lati kezel\u00e9s, a helysz\u00edni vizitek \u00e9s a vizsg\u00e1lattal kapcsolatos tesztek k\u00f6lts\u00e9geit a klinikai vizsg\u00e1lat megb\u00edz\u00f3ja, az IDRx, Inc. fedezi, \u00d6nnek semmilyen k\u00f6lts\u00e9ge nem keletkezik. A vizsg\u00e1lati l\u00e1togat\u00e1sokkal kapcsolatos \u00e9sszer\u0171 utaz\u00e1si k\u00f6lts\u00e9geket megt\u00e9r\u00edtj\u00fck \u00d6nnek.&#8221;]K\u00f6lts\u00e9gekkel j\u00e1r sz\u00e1momra, ha r\u00e9szt veszek a vizsg\u00e1latban?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;430406&#8243; subheading=&#8221;A klinikai vizsg\u00e1latban val\u00f3 r\u00e9szv\u00e9tel \u00f6nk\u00e9ntes. Ha \u00fagy d\u00f6nt, hogy r\u00e9szt vesz, majd meggondolja mag\u00e1t, b\u00e1rmikor kil\u00e9phet a vizsg\u00e1latb\u00f3l. A vizsg\u00e1latb\u00f3l val\u00f3 kil\u00e9p\u00e9s nem befoly\u00e1solja a szok\u00e1sos orvosi ell\u00e1t\u00e1s\u00e1t.&#8221;]Mi t\u00f6rt\u00e9nik, ha \u00fagy d\u00f6nt\u00f6k, hogy r\u00e9szt veszek a vizsg\u00e1latban, majd meggondolom magam?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;115706&#8243; text_color_type=&#8221;uncode-palette&#8221;]Vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nnyel kapcsolatos k\u00e9rd\u00e9sek[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;138330&#8243; subheading=&#8221;A GIST megbeteged\u00e9st gyakran a KIT nev\u0171 norm\u00e1lis sejtfeh\u00e9rje g\u00e9nj\u00e9nek v\u00e1ltoz\u00e1sai vagy mut\u00e1ci\u00f3i okozz\u00e1k. Ezek a mut\u00e1ci\u00f3k a KIT t\u00falaktiv\u00e1l\u00f3d\u00e1s\u00e1hoz vezetnek \u2013 mintha egy kapcsol\u00f3 beragadt volna a bekapcsolt helyzetben \u2013, ami a r\u00e1kos sejtek szaporod\u00e1s\u00e1t okozza.<\/p>\n<p>Az IDRX-42 egy tirozin-kin\u00e1z inhibitor (TKI). A TKI-k le\u00e1ll\u00edtj\u00e1k vagy lelass\u00edtj\u00e1k a KIT aktivit\u00e1s\u00e1t \u00e9s a r\u00e1kos sejtek abb\u00f3l k\u00f6vetkez\u0151 n\u00f6veked\u00e9s\u00e9t. M\u00e1s TKI-kat is haszn\u00e1lnak a GIST kezel\u00e9s\u00e9re, de azok nem minden <i>KIT<\/i> mut\u00e1ci\u00f3 ellen hatnak. Az IDRX-42-t \u00fagy tervezt\u00e9k meg, hogy a <i>KIT<\/i> mut\u00e1ci\u00f3k sz\u00e9lesebb spektrum\u00e1t lefedje.&#8221; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243;]Mi az IDRX-42?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;172011&#8243; subheading=&#8221;Mint minden gy\u00f3gyszer eset\u00e9ben, itt is el\u0151fordulhatnak mell\u00e9khat\u00e1sok, amelyek a gy\u00f3gyszer nem k\u00edv\u00e1nt vagy nem sz\u00e1nd\u00e9kolt hat\u00e1sai. A lehets\u00e9ges mell\u00e9khat\u00e1sokr\u00f3l tov\u00e1bbi inform\u00e1ci\u00f3k\u00e9rt forduljon a vizsg\u00e1l\u00f3orvoshoz. Eg\u00e9szs\u00e9gi \u00e1llapot\u00e1t a vizsg\u00e1lat teljes id\u0151tartama alatt szorosan figyelemmel k\u00eds\u00e9rj\u00fck. Ha b\u00e1rmilyen mell\u00e9khat\u00e1st vagy eg\u00e9szs\u00e9gi \u00e1llapot\u00e1ban bek\u00f6vetkezett v\u00e1ltoz\u00e1st \u00e9szlel, \u00e9rtes\u00edtse a vizsg\u00e1l\u00f3orvost.&#8221;]Vannak-e mell\u00e9khat\u00e1sai a vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nyeknek?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;114741&#8243; subheading=&#8221;Igen, a vizsg\u00e1l\u00f3orvos t\u00e1j\u00e9koztatni fogja \u00d6nt arr\u00f3l, hogy melyik vizsg\u00e1lati kezel\u00e9st kapja.<\/p>\n<p>Ha szunitinib kezel\u00e9st kapok, akkor is lesz es\u00e9lyem IDRX-42 kezel\u00e9st kapni? Ha szunitinib kezel\u00e9st kap, \u00e9s daganatos megbeteged\u00e9se s\u00falyosbodik, akkor lehet\u0151s\u00e9ge van az IDRX-42 kezel\u00e9sre v\u00e1ltani.&#8221; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243;]Tudni fogom, hogy az IDRX-42-t vagy szunitinibet kapok?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;123134&#8243; text_color_type=&#8221;uncode-palette&#8221;]StrateGIST 3 k\u00e9rd\u00e9sek[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;699296&#8243; subheading=&#8221;A vizsg\u00e1latban legfeljebb 5,5 \u00e9vig vehet r\u00e9szt. Mint minden klinikai vizsg\u00e1lat eset\u00e9ben, \u00d6n b\u00e1rmikor, b\u00e1rmilyen okb\u00f3l vagy ok n\u00e9lk\u00fcl abbahagyhatja a r\u00e9szv\u00e9telt. Az IDRX, Inc. nem tervezi, hogy a vizsg\u00e1lat befejez\u00e9se ut\u00e1n, vagy ha \u00d6n abbahagyta a vizsg\u00e1latot, vagy kiz\u00e1rt\u00e1k a vizsg\u00e1latb\u00f3l, IDRX-42-t vagy b\u00e1rmely m\u00e1s vizsg\u00e1lati gy\u00f3gyszert vagy elj\u00e1r\u00e1st biztos\u00edtson \u00d6nnek.&#8221;]Mennyi ideig fogok r\u00e9szt venni a vizsg\u00e1latban?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;127156&#8243; subheading=&#8221;Ha alkalmasnak bizonyul a vizsg\u00e1latra, v\u00e9letlenszer\u0171en beker\u00fcl egy csoportba, amelyben vagy IDRX-42-t, vagy szunitinibet kap, amely egyes orsz\u00e1gokban a vizsg\u00e1lt GIST t\u00edpusra j\u00f3v\u00e1hagyott kezel\u00e9s.&#8221;]Milyen vizsg\u00e1lati kezel\u00e9st kapok?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;514493&#8243; subheading=&#8221;Az IDRX-42 tabletta form\u00e1tum\u00fa, amelyet v\u00edzzel kell bevenni (\u00e9tellel vagy an\u00e9lk\u00fcl). Az IDRX-42-t naponta egyszer kell bevenni, a vizsg\u00e1latot v\u00e9gz\u0151 orvos utas\u00edt\u00e1sainak megfelel\u0151en. Az IDRX-42 szed\u00e9s\u00e9t addig kell folytatni, am\u00edg a daganat nem s\u00falyosbodik, \u00e9s a beteg a kezel\u00e9st j\u00f3l toler\u00e1lja.&#8221;]Hogyan kell szedni az IDRX-42-t?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;355188&#8243; subheading=&#8221;A szunitinib kapszula form\u00e1tum\u00fa, amelyet v\u00edzzel kell bevenni (\u00e9tellel vagy an\u00e9lk\u00fcl). A szunitinibot naponta egyszer, 28 napig kell szedni, majd 14 napos sz\u00fcnet k\u00f6vetkezik, hacsak m\u00e1s utas\u00edt\u00e1s nincs. A szunitinib szed\u00e9s\u00e9t addig kell folytatni, am\u00edg a daganat nem s\u00falyosbodik, \u00e9s a beteg a kezel\u00e9st j\u00f3l toler\u00e1lja. Ha a szunitinib szed\u00e9se alatt a daganat s\u00falyosbodik, akkor \u00e1t\u00e1llhat az IDRX-42-re.&#8221;]Hogyan kell szedni a szunitinibot?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;700478&#8243;]Mely klinikai vizsg\u00e1lati helysz\u00ednek vesznek r\u00e9szt a StrateGIST 3 programban?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;480045&#8243; css=&#8221;.vc_custom_1732655988927{margin-top: 10px !important;}&#8221;]Kattintson <a href=\"\/#location\">ide<\/a> a r\u00e9szt vev\u0151 helysz\u00ednek list\u00e1j\u00e1nak megtekint\u00e9s\u00e9hez \u00e9s a legk\u00f6zelebbi helysz\u00edn megtal\u00e1l\u00e1s\u00e1hoz.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;112276&#8243; back_attachment=&#8221;fixed&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; top_divider=&#8221;step_1_2&#8243; medium_visibility=&#8221;yes&#8221; changer_back_color=&#8221;yes&#8221; uncode_shortcode_id=&#8221;111832&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;questions&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;5&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;166430&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;384218&#8243; text_color_type=&#8221;uncode-palette&#8221;]\u00c1ltal\u00e1nos k\u00e9rd\u00e9sek[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;204481&#8243; subheading=&#8221;Nincs garant\u00e1lt el\u0151ny, azonban az \u00d6n eg\u00e9szs\u00e9gi \u00e1llapot\u00e1t a StrateGIST 3 vizsg\u00e1lat sor\u00e1n folyamatosan figyelemmel k\u00eds\u00e9rj\u00fck. M\u00e9g ha \u00d6nnek k\u00f6zvetlen\u00fcl nem is sz\u00e1rmazik el\u0151nye a vizsg\u00e1latban val\u00f3 r\u00e9szv\u00e9telb\u0151l, az \u00f6sszegy\u0171jt\u00f6tt inform\u00e1ci\u00f3k seg\u00edthetnek a kutat\u00f3knak t\u00f6bbet megtudni az IDRX-42 (GSK6042981) vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nyr\u0151l \u00e9s a GIST-ben szenved\u0151 feln\u0151ttek j\u00f6v\u0151beli kezel\u00e9s\u00e9r\u0151l.&#8221;]Milyen el\u0151ny\u00f6kkel j\u00e1r a StrateGIST 3 programban val\u00f3 r\u00e9szv\u00e9tel?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;104022&#8243; subheading=&#8221;Mint minden gy\u00f3gyszer eset\u00e9ben, a vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nyekn\u00e9l is fenn\u00e1ll a mell\u00e9khat\u00e1sok kock\u00e1zata. Azonban az \u00d6n biztons\u00e1ga a legfontosabb sz\u00e1munkra. Eg\u00e9szs\u00e9gi \u00e1llapot\u00e1t a vizsg\u00e1lat teljes id\u0151tartama alatt szorosan figyelemmel k\u00eds\u00e9rj\u00fck. &#8222;]Van-e kock\u00e1zata a vizsg\u00e1latban val\u00f3 r\u00e9szv\u00e9telnek?[\/vc_custom_heading][vc_custom_heading 1=&#8221;biopharmaceutical&#8221; 2=&#8221;company&#8221; 3=&#8221;IDRx,&#8221; 4=&#8221;Inc.&#8221; 5=&#8221;is&#8221; 6=&#8221;sponsoring&#8221; 7=&#8221;the&#8221; 8=&#8221;clinical&#8221; 9=&#8221;trial.&#8221; 10=&#8221;They&#8221; 11=&#8221;will&#8221; 12=&#8221;pay&#8221; 13=&#8221;the&#8221; 14=&#8221;study&#8221; 15=&#8221;doctor&#8221; 16=&#8221;and&#8221; 17=&#8221;site&#8221; 18=&#8221;staff&#8221; 19=&#8221;to&#8221; 20=&#8221;run&#8221; 21=&#8221;this&#8221; 22=&#8221;trial.&#8221; 23=&#8221;To&#8221; 24=&#8221;learn&#8221; 25=&#8221;more&#8221; 26=&#8221;about&#8221; 27=&#8221;IDRx,&#8221; 28=&#8221;visit&#8221; 29=&#8221;&#8221; 30=&#8221;href=&#8222;&#8222;https:\/\/www.idrx.com&#8222;&#8222;&gt;www.idrx.com&#8221; 31=&#8221;.&#8222;&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;657637&#8243;]Ki a StrateGIST 3 klinikai vizsg\u00e1lat megb\u00edz\u00f3ja?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;779402&#8243; css=&#8221;.vc_custom_1755617742215{margin-top: 10px !important;}&#8221;]<span style=\"font-weight: 400;\">A glob\u00e1lis biogy\u00f3gyszeripari v\u00e1llalat, a GSK finansz\u00edrozza a StrateGIST 3 klinikai vizsg\u00e1latot. A vizsg\u00e1lat lebonyol\u00edt\u00e1s\u00e1\u00e9rt fizet\u00e9st kapnak a vizsg\u00e1latot v\u00e9gz\u0151 orvosok \u00e9s a helysz\u00edni szem\u00e9lyzet. A GSK-r\u00f3l tov\u00e1bbi inform\u00e1ci\u00f3kat a <\/span><a href=\"https:\/\/us.gsk.com\/en-us\/\" target=\"_blank\" rel=\"noopener\">www.gsk.com<\/a> weboldalon tal\u00e1l.[\/vc_column_text][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;116327&#8243; subheading=&#8221;A vizsg\u00e1lati kezel\u00e9s, a helysz\u00edni vizitek \u00e9s a vizsg\u00e1lattal kapcsolatos tesztek k\u00f6lts\u00e9geit a klinikai vizsg\u00e1lat megb\u00edz\u00f3ja, a GSK fedezi, \u00edgy \u00d6nnek semmilyen k\u00f6lts\u00e9ge nem keletkezik. A vizsg\u00e1lati l\u00e1togat\u00e1sokkal kapcsolatos \u00e9sszer\u0171 utaz\u00e1si k\u00f6lts\u00e9geket megt\u00e9r\u00edthetj\u00fck \u00d6nnek.&#8221;]K\u00f6lts\u00e9gekkel j\u00e1r sz\u00e1momra, ha r\u00e9szt veszek a vizsg\u00e1latban?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;430406&#8243; subheading=&#8221;A klinikai vizsg\u00e1latban val\u00f3 r\u00e9szv\u00e9tel \u00f6nk\u00e9ntes. Ha \u00fagy d\u00f6nt, hogy r\u00e9szt vesz, majd meggondolja mag\u00e1t, b\u00e1rmikor kil\u00e9phet a vizsg\u00e1latb\u00f3l. A vizsg\u00e1latb\u00f3l val\u00f3 kil\u00e9p\u00e9s nem befoly\u00e1solja a szok\u00e1sos orvosi ell\u00e1t\u00e1s\u00e1t.&#8221;]Mi t\u00f6rt\u00e9nik, ha \u00fagy d\u00f6nt\u00f6k, hogy r\u00e9szt veszek a vizsg\u00e1latban, majd meggondolom magam?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;115706&#8243; text_color_type=&#8221;uncode-palette&#8221;]Vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nnyel kapcsolatos k\u00e9rd\u00e9sek[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;159505&#8243; subheading=&#8221;A GIST megbeteged\u00e9st gyakran a KIT nev\u0171 norm\u00e1lis sejtfeh\u00e9rje g\u00e9nj\u00e9nek v\u00e1ltoz\u00e1sai vagy mut\u00e1ci\u00f3i okozz\u00e1k. Ezek a mut\u00e1ci\u00f3k a KIT t\u00falaktiv\u00e1l\u00f3d\u00e1s\u00e1hoz vezetnek \u2013 mintha egy kapcsol\u00f3 beragadna a bekapcsolt helyzetben \u2013, ami a r\u00e1kos sejtek szaporod\u00e1s\u00e1t okozza.<\/p>\n<p>Az IDRX-42 (GSK6042981) egy tirozin-kin\u00e1z inhibitor (TKI). A TKI-k le\u00e1ll\u00edtj\u00e1k vagy lelass\u00edtj\u00e1k a KIT aktivit\u00e1s\u00e1t \u00e9s a r\u00e1kos sejtek abb\u00f3l k\u00f6vetkez\u0151 n\u00f6veked\u00e9s\u00e9t. M\u00e1s TKI-kat is haszn\u00e1lnak a GIST kezel\u00e9s\u00e9re, de azok nem minden KIT mut\u00e1ci\u00f3 ellen hatnak. Az IDRX-42-t (GSK6042981) \u00fagy tervezt\u00e9k meg, hogy a KIT mut\u00e1ci\u00f3k sz\u00e9lesebb spektrum\u00e1t lefedje.&#8221; text_color_type=&#8221;uncode-palette&#8221; text_color_solid=&#8221;#ff0000&#8243;]Mi az IDRX-42 (GSK6042981)?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;172011&#8243; subheading=&#8221;Mint minden gy\u00f3gyszer eset\u00e9ben, itt is el\u0151fordulhatnak mell\u00e9khat\u00e1sok, amelyek a gy\u00f3gyszer nem k\u00edv\u00e1nt vagy nem sz\u00e1nd\u00e9kolt hat\u00e1sai. A lehets\u00e9ges mell\u00e9khat\u00e1sokr\u00f3l tov\u00e1bbi inform\u00e1ci\u00f3k\u00e9rt forduljon a vizsg\u00e1l\u00f3orvoshoz. Eg\u00e9szs\u00e9gi \u00e1llapot\u00e1t a vizsg\u00e1lat teljes id\u0151tartama alatt szorosan figyelemmel k\u00eds\u00e9rj\u00fck. Ha b\u00e1rmilyen mell\u00e9khat\u00e1st vagy eg\u00e9szs\u00e9gi \u00e1llapot\u00e1ban bek\u00f6vetkezett v\u00e1ltoz\u00e1st \u00e9szlel, \u00e9rtes\u00edtse a vizsg\u00e1l\u00f3orvost.&#8221;]Vannak-e mell\u00e9khat\u00e1sai a vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9nyeknek?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;970928&#8243; subheading=&#8221;Igen, a vizsg\u00e1l\u00f3orvos t\u00e1j\u00e9koztatni fogja \u00d6nt arr\u00f3l, hogy melyik vizsg\u00e1lati kezel\u00e9st kapja.&#8221;]Tudni fogom, hogy IDRX-42 (GSK6042981)<br \/>\nvagy szunitinib kezel\u00e9st kapok?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;123134&#8243; text_color_type=&#8221;uncode-palette&#8221;]StrateGIST 3 k\u00e9rd\u00e9sek[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;759072&#8243; subheading=&#8221;A vizsg\u00e1latban legfeljebb 5 \u00e9vig fog r\u00e9szt venni. Mint minden klinikai vizsg\u00e1lat eset\u00e9ben, \u00d6n b\u00e1rmikor, b\u00e1rmilyen okb\u00f3l vagy ok n\u00e9lk\u00fcl abbahagyhatja a r\u00e9szv\u00e9telt. A GSK nem tervezi az IDRX-42 (GSK6042981) vagy b\u00e1rmely m\u00e1s vizsg\u00e1lati k\u00e9sz\u00edtm\u00e9ny vagy elj\u00e1r\u00e1s biztos\u00edt\u00e1s\u00e1t \u00d6nnek a vizsg\u00e1lat befejez\u00e9se ut\u00e1n, illetve abban az esetben, ha \u00d6n abbahagyta a vizsg\u00e1latot vagy abb\u00f3l kivont\u00e1k.&#8221;]Mennyi ideig fogok r\u00e9szt venni a vizsg\u00e1latban?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;124602&#8243; subheading=&#8221;Ha alkalmasnak bizonyul a vizsg\u00e1latra, v\u00e9letlenszer\u0171en beker\u00fcl egy csoportba, amelyben vagy IDRX-42-t (GSK6042981), vagy szunitinibet kap, amely egyes orsz\u00e1gokban a vizsg\u00e1lt GIST t\u00edpusra j\u00f3v\u00e1hagyott kezel\u00e9s. A vizsg\u00e1lat v\u00e9g\u00e9n, ha \u00d6n megfelel a felt\u00e9teleknek, a GSK a helyi szab\u00e1lyoz\u00e1sokt\u00f3l f\u00fcgg\u0151en k\u00fcl\u00f6n hozz\u00e1f\u00e9r\u00e9si program keret\u00e9ben hozz\u00e1f\u00e9r\u00e9st biztos\u00edthat az IDRX-42 (GSK6042981) k\u00e9sz\u00edtm\u00e9nyhez.&#8221;]Milyen vizsg\u00e1lati kezel\u00e9st kapok?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;191460&#8243; subheading=&#8221;Az IDRX-42 (GSK6042981) tabletta form\u00e1tum\u00fa, amelyet v\u00edzzel kell bevenni (\u00e9tellel vagy an\u00e9lk\u00fcl). Az IDRX-42-t (GSK6042981) naponta egyszer kell bevenni, a vizsg\u00e1l\u00f3orvos utas\u00edt\u00e1sainak megfelel\u0151en. Az IDRX-42 (GSK6042981) szed\u00e9s\u00e9t addig kell folytatni, am\u00edg a daganat nem s\u00falyosbodik, \u00e9s a beteg a kezel\u00e9st j\u00f3l toler\u00e1lja.&#8221;]Hogyan kell szedni az IDRX-42-t (GSK6042981)?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152983&#8243; subheading=&#8221;A szunitinib kapszula form\u00e1tum\u00fa, amelyet v\u00edzzel kell bevenni (\u00e9tellel vagy an\u00e9lk\u00fcl). A szunitinibot naponta egyszer, 28 napig kell szedni, majd 14 napos sz\u00fcnet k\u00f6vetkezik, hacsak m\u00e1s utas\u00edt\u00e1s nincs. A szunitinib szed\u00e9s\u00e9t addig kell folytatni, am\u00edg a daganat nem s\u00falyosbodik, \u00e9s a beteg a kezel\u00e9st j\u00f3l toler\u00e1lja.&#8221;]Hogyan kell szedni a szunitinibot?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;700478&#8243;]Mely klinikai vizsg\u00e1lati helysz\u00ednek vesznek r\u00e9szt a StrateGIST 3 programban?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;480045&#8243; css=&#8221;.vc_custom_1732655988927{margin-top: 10px !important;}&#8221;]Kattintson <a href=\"\/#location\">ide<\/a> a r\u00e9szt vev\u0151 helysz\u00ednek list\u00e1j\u00e1nak megtekint\u00e9s\u00e9hez \u00e9s a legk\u00f6zelebbi helysz\u00edn megtal\u00e1l\u00e1s\u00e1hoz.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-138782","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/pages\/138782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/comments?post=138782"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/pages\/138782\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/hu\/wp-json\/wp\/v2\/media?parent=138782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}